Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 174

1.

Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB.

Vargas MP, Vargas HI, Kleiner DE, Merino MJ.

Am J Surg Pathol. 1997 May;21(5):556-62.

PMID:
9158680
[PubMed - indexed for MEDLINE]
2.

The role of prognostic markers (MiB-1, RB, and bcl-2) in the diagnosis of parathyroid tumors.

Vargas MP, Vargas HI, Kleiner DE, Merino MJ.

Mod Pathol. 1997 Jan;10(1):12-7.

PMID:
9021722
[PubMed - indexed for MEDLINE]
3.
4.
5.

Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.

Goldblum JR, Shannon R, Kaldjian EP, Thiny M, Davenport R, Thompson N, Lloyd RV.

Mod Pathol. 1993 Nov;6(6):663-8.

PMID:
7508113
[PubMed - indexed for MEDLINE]
6.

p53 and Ki67 in adrenocortical tumors.

Arola J, Salmenkivi K, Liu J, Kahri AI, Heikkilä P.

Endocr Res. 2000 Nov;26(4):861-5.

PMID:
11196463
[PubMed - indexed for MEDLINE]
7.

Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.

Martins AC, Cologna AJ, Tucci S Jr, Suaid HJ, Falconi RA.

J Urol. 2005 Jun;173(6):2138-42.

PMID:
15879867
[PubMed - indexed for MEDLINE]
8.

Immunohistochemical expression of bcl-2 and p53 oncoproteins: correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia.

Saleh HA, Jackson H, Banerjee M.

Appl Immunohistochem Mol Morphol. 2000 Sep;8(3):175-82.

PMID:
10981868
[PubMed - indexed for MEDLINE]
9.

Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.

Nakazumi H, Sasano H, Iino K, Ohashi Y, Orikasa S.

Mod Pathol. 1998 Dec;11(12):1165-70.

PMID:
9872646
[PubMed - indexed for MEDLINE]
10.

Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues.

Naccarato AG, Marcocci C, Miccoli P, Bonadio AG, Cianferotti L, Vignali E, Cipollini G, Viacava P.

J Endocrinol Invest. 1998 Mar;21(3):136-41.

PMID:
9591207
[PubMed - indexed for MEDLINE]
11.

p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr.

Neurosurgery. 1996 Apr;38(4):765-70; discussion 770-1.

PMID:
8692397
[PubMed - indexed for MEDLINE]
12.

Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues.

Bernini GP, Moretti A, Viacava P, Bonadio AG, Iacconi P, Miccoli P, Salvetti A.

Br J Cancer. 2002 May 20;86(10):1561-5.

PMID:
12085205
[PubMed - indexed for MEDLINE]
Free PMC Article
13.
14.

Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.

Ioachim E, Assimakopoulos D, Agnantis NJ, Peschos D, Zissi A, Skevas A.

Anticancer Res. 1999 Jan-Feb;19(1A):541-5.

PMID:
10226595
[PubMed - indexed for MEDLINE]
15.

Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.

Sharma M, Ralte A, Arora R, Santosh V, Shankar SK, Sarkar C.

Pathology. 2004 Apr;36(2):139-44.

PMID:
15203749
[PubMed - indexed for MEDLINE]
16.

Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.

Claudio PP, Zamparelli A, Garcia FU, Claudio L, Ammirati G, Farina A, Bovicelli A, Russo G, Giordano GG, McGinnis DE, Giordano A, Cardi G.

Clin Cancer Res. 2002 Jun;8(6):1808-15.

PMID:
12060621
[PubMed - indexed for MEDLINE]
Free Article
17.

Pathobiology of pituitary adenomas and carcinomas.

Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, Yapicier O, Young WF Jr, Meyer FB, Kuroki T, Riehle DL, Laws ER Jr.

Neurosurgery. 2006 Aug;59(2):341-53; discussion 341-53.

PMID:
16883174
[PubMed - indexed for MEDLINE]
18.

Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.

Takehara K, Sakai H, Shono T, Irie J, Kanetake H.

Int J Urol. 2005 Feb;12(2):121-7.

PMID:
15733104
[PubMed - indexed for MEDLINE]
19.

IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.

Schmitt A, Saremaslani P, Schmid S, Rousson V, Montani M, Schmid DM, Heitz PU, Komminoth P, Perren A.

Histopathology. 2006 Sep;49(3):298-307.

PMID:
16918977
[PubMed - indexed for MEDLINE]
20.

Usefulness of endoscopic biopsy using immunostaining of p53 and Ki-67 in tumors of the ampulla of Vater.

Kubota K, Kakuta Y, Kawamura S, Saito S, Seki H, Kuniyoshi T.

Pathol Int. 2003 Jun;53(6):361-70.

PMID:
12787310
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk